CX-4945

silmitasertib · Senhwa Biosciences

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for CX-4945, covering 2011-06-15 to 2026-01-08. Get the full timeline:

Most recent: Clinical Trial Update: CX-4945 in Viral Community Acquired Pneumonia [Phase 2]